Company type
Discovery, development, commercialization and manufacturing of biotherapeutics by using human genetic informationFunding rounds
Actual initial investment stage
Series A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 11 of 11| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Bayhill Therapeutics | A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. | N/A | |||
|
|
Cellective Therapeutics Inc | N/A | ||||
|
|
CGI Pharmaceuticals Inc | A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. | N/A | |||
|
|
InterMune Inc | Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. | N/A | |||
|
|
Intradigm Corp | N/A | ||||
|
|
Kereos Inc | Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. | N/A | |||
|
|
OncoMed Pharmaceuticals Inc | Biotechnology company focused on scientific discoveries of cancer stem cells in solid tumors. | N/A | |||
|
|
OncoMed Pharmaceuticals Inc | Biotechnology company focused on scientific discoveries of cancer stem cells in solid tumors. | N/A | |||
|
|
Proacta Inc | Series A | ||||
|
|
Tolerx Inc | Developer of a novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. | N/A | |||
|
23andMe Inc | DNA testing and genome sequencing firm. | Series A Initial investment |
Current team
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
|
Megan Quinn | Niantic Inc |